TScan Therapeutics
TCRX
TCRX
66 hedge funds and large institutions have $272M invested in TScan Therapeutics in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
22% more funds holding
Funds holding: 54 → 66 (+12)
4.82% more ownership
Funds ownership: 73.82% → 78.64% (+4.8%)
Holders
66
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$3.88M | |
| 2 | +$2.4M | |
| 3 | +$2.33M | |
| 4 |
Goldman Sachs
New York
|
+$1.83M |
| 5 |
TAM
Tocqueville Asset Management
New York
|
+$1.68M |
Top Sellers
| 1 | -$1.95M | |
| 2 | -$252K | |
| 3 | -$223K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$199K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$151K |